期刊文献+

5/6肾切除对尿毒症心衰大鼠主动脉NO病理生理机制的影响研究

Impact study of aortic NO pathologic physiology mechanism of 5/6 nephrectomy to rats with uremia heart failure
下载PDF
导出
摘要 目的探讨5/6肾切除对尿毒症心衰大鼠一氧化氮(NO)病理生理机制的影响。方法将50只雄性SD大鼠随机分为肾切除(NX)组30只和假手术(Sham)组20只。2组常规检测血清尿素氮(BUN)、肌酐(Scr)及24h尿蛋白定量,采用Griess法测定NO含量和一氧化氮合酶(NOS)活性,实时定量聚合酶链式反应(RT-PCR)检测内皮型NOS(eNOS)和诱导型NOS(iNOS)的基因表达。结果 NX组术后第6、8周血清BUN、肌酐Scr及24h尿蛋白定量均高于Sham组;eNOS活性低于Sham组;eNOSmRNA的表达水平低于Sham组,iNOSmRNA的表达水平高于Sham组,差异均有统计学意义(P<0.05和P<0.01)。结论主动脉(包括血管内皮细胞)被损伤后,iNOS增加,而eNOS减少,从而使主动脉的舒张度降低而最终导致心衰。对于5/6肾切除大鼠,受损的主动脉NO途径可能是尿毒症诱发心衰的机制之一。 Objective To investigate the pathophysiological mechanisms of NO system of 5/6 nephrectomy to rats with uremia heart failure.Methods 50 male SD rats were randomly divided into NX group(30 cases) and Sham group(20 cases).The BUN,Scr and 24h proteinuria excretion of 2 groups were tested routinely.The NO contents and NOS activity were assayed by Griess method,and the iNOS and eNOS expression were assayed by RT-PCR.Results The BUN,Scr and 24h proteinuria excretion at postoperative 6,8 weeks of the NX group were higher than that of the Sham group;the eNOS activity of the NX group was lower than that of the Sham group;the mRNA expression level of eNOS of the NX group was lower than that of the Sham group;the mRNA expression level of iNOS of the NX group was higher than that of the Sham group,the differences were statistically significant(P〈0.05 and P〈0.01).Conclusion After aorta(including endothelium) was injured,iNOS derived NO increasing and meanwhile eNOS derived NO decreasing,so that,aortic relaxing tension was declined,which may finally cause heart failure.Injured aortic NO pathway in 5/6 nephrectomized rats may be one of the mechanism of uremia-induced heart failure.
出处 《临床合理用药杂志》 2012年第20期1-3,共3页 Chinese Journal of Clinical Rational Drug Use
关键词 尿毒症心衰 一氧化氮 一氧化氮合酶 Uremia heart failure Nitric oxide Nitric oxide synthase
  • 相关文献

参考文献2

二级参考文献13

  • 1Mariell Jessup,Maria Rosa Costanzo,et al The Cardiorenal Syndrome Do We Need a Changeof Strategy or a Change of Tactics?,Journal of the American College of Cardiology 2009,53:597-9.
  • 2Ralf Westenfeld,WiUi Jahnen-Dechent,et al Vascular Calcification and Fetuin-A Deficiency in Chronic Kidney Disease,Trends Cardiovasc Med 2007,17:124-128.
  • 3Shuichi Tsuruoka,Kenta Nishiki,et ai Chronopharmacology of oxacalcitriol in 5/6 nephrectomized rats.
  • 4A.Imam,M.Aigbe,et al,The effect of IGF-1 and Enaiapril therapy on renal function and tubular apoptosis in growing rats with chronic renal failure,Kidney and Hypertension,2000,13(4):286A-287A.
  • 5Aarsen P N,Kemp A.Rapid spectrophotometric micromethod for determination of histaminase activity[J].Nature,1964,204:119.
  • 6Doris T.Chan,Ashley B.Irish,et al,Dyslipidaemia and cardiorenal disease:mechanisms,therapeutic opportunities and clinical trials,Atheroselernsis,2008,196:823-834.
  • 7Claudio Ronco,Mikko Haapio MD,et al Cardiorenal Syndrome,Journal of the American College of Cardiology,2008,52 (19):1527-1539.
  • 8Mario Cozzolino,Maurizio Gallieni,et al,Cytokine.
  • 9Mei Y.Speer,Cecilia M.Giachelli,et al,Regulation of cardiovascular calcification Cardiovascular Pathology,2004,13:63-70.
  • 10Sheila Au,and Richard L Crawford,et al,Three-dimensional analysis of a caiciphylaxis plaque:Clues to pathogenesis J Am Acad Dormatol 2002,47:53-7.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部